IL6 and chronic kidney disease: Levels of pro-inflammatory molecules Interleukin (IL)-6, IL-1 and Tumor Necrosis Factor (TNF)-α are higher even in patients in the early stages of CKD, and this inflammation appears to influence CKD progression.